Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-004098

Chief Scientific Officer sold 582,023 shares at $2.08 ($1,213,402)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mor George Adi Chief Scientific Officer 2022-11-16 Sale −324,775 $2.08 $677,091 324,775 D: show line 1 in the form
Mor George Adi Chief Scientific Officer 2022-11-16 Sale −257,248 $2.08 $536,311 257,247 I: show line 2 in the form
Open-market sales · 582,023 sh · avg $2.08 · $1,213,402

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mor George Adi Chief Scientific Officer 2018-03-15 Grant or award · Option to Purchase American Depositary Shares +131,698 131,698 D: show line 3 in the form
Mor George Adi Chief Scientific Officer 2016-10-28 Grant or award · Option to Purchase American Depositary Shares +33,725 33,725 I: show line 4 in the form
Loading xslF345X03/ownership.xml…